Denmark announced that they would stop completely using Astrazeneca vaccine, becoming the first European country to do so because of the rare side effects.

"Denmark's vaccination campaign will continue without vaccine Astrazeneca", Director of Danish Health Agency Soren Brodrom said in the press conference in Copenhagen on April 14.

A nurse preparing for Astrazeneca vaccination in the UK on April 9.

In mid-March, Denmark was the first country in Europe to use Astrazeneca when there was information about cases of rare coagulation but serious after this vaccine.

However, Denmark continues to stop using vaccines when they conduct surveys.

EMA on April 7 suggested that the blood clotting is "very rare side effects" of Astrazeneca vaccine, but it is recommended that countries should continue to use, affirming "benefits it greater than the risk of effect

With the latest announcement, Denmark is the first country in Europe to stop completely using Astrazeneca vaccine.

Stopping using Astrazeneca will delay the country's ambitious vaccination plan, but the Danish Health Agency said that with other types of vaccines they own and the translation situation are being controlled and campaign